Eric Bernstein MD MSE
Eric F. Bernstein, M.D., M.S.E. earned a Bachelor of Science degree from Duke University in 1981 graduating Phi Beta Kappa, summa cum laude with distinction in his major. He then earned his degree in medicine from Yale University School of Medicine in 1986 where he served as Banner Bearer at commencement exercises and class president. He completed a fellowship at the NCI at NIH, investigating PDT and cytokines for wound healing. Dr Bernstein served as Associate Professor in the Department of Dermatology and Cutaneous Biology at Jefferson Medical College where he directed a photobiology laboratory and founded the Laser Surgery Center. Dr Bernstein’s research focused on the molecular causes of skin photoaging and its repair. He also earned an M.S.E. in Management of Technology from the School of Engineering and Applied Science at the University of Pennsylvania, co-administered by the Wharton School.
Dr Bernstein is founder/director of the Main Line Center for Laser Surgery. He served as president of the ASLMS, and serves on numerous laser company scientific advisory boards, and was a Director for Candela Corporation. He is a consultant for numerous medical laser companies, co-founder and CMO of Acclaro, Inc., co-founder and director of Cellviva, Inc., and founder and CEO of Phase Shield, LLC. Dr Bernstein founded DakDak Photoaging Technologies receiving an SBIR grant from NIH to commercialize a molecular model of skin photoaging. This company was sold to Charles River Laboratories (CRL). Dr Bernstein has also served as a director for Once Again Me, Inc., Intellectual Light, Inc., Chairman of Freedom-2 Inc., and co-founded American Medical Media, Inc (AMM). which was sold to InterActive Corp. (IAC). Call Compass, LLC was spun out of AMM and Dr Bernstein now serves as CEO, directing licensing of its patent portfilio. Dr Bernstein founded and recently sold Alethia, LLC, a skincare company with the associated IP to a privately held aesthetic company.
Dr Bernstein currently serves as volunteer faculty at the University of Pennsylvania and Temple University in the Department of Dermatology as a Clinical Professor. He has authored over 100 peer-reviewed articles and over 15 U.S. and international patents in addition to giving more than 400 presentations at scientific meetings.
